Schisandrin B can attenuate Aβ‐induced cellular damage and cognitive impairment in AD mice and may act as a potential selective ATP‐competitive GSK‐3β inhibitor, further affecting its anti‐AD effect.149. The gene discussed is GSK3B; the disease is Cognitive impairment.